# Paradigm Biocapital Advisors LP 13F Q2 2026: $5.3 billion

Paradigm Biocapital Advisors LP reported $5.3 billion in 13F securities across 28 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Revolution Medicines Inc at $1.2 billion, 22.3% of the reported value. Since Q1 2026 it opened 7 new positions and exited 14.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $5,340,558,034
- Positions: 28
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1855655
- Form 13F file number: 028-21950
- CRD number: 312544
- Business address: 520 Fifth Avenue, 23rd Floor, New York, NY 10036
- SEC filing: [0001855655-26-000014](https://www.sec.gov/Archives/edgar/data/1855655/000185565526000014/0001855655-26-000014-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/paradigm-biocapital-advisors-lp-312544)

## Top 25 holdings by value

The largest of 28 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 6,361,323 | $1.19 billion | -294,380 |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 5,924,433 | $731.7 million | +600,000 |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 10,215,455 | $415.1 million | +2,850,417 |
| [Genmab A/S](https://specstream.ai/data/institutional-holders/genmab-a-s-372303206) | SPONSORED ADS | 13,133,131 | $360.8 million | +5,165,295 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 3,840,778 | $341 million | +1,883,512 |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 1,576,385 | $209.2 million | +228,142 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 2,144,526 | $204.1 million | -175,790 |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 6,357,523 | $198.7 million | +2,347,844 |
| [Belite Bio Inc](https://specstream.ai/data/institutional-holders/belite-bio-inc-07782b104) | SPONSORED ADS | 1,232,877 | $189.8 million | +118,093 |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 9,550,000 | $175 million | -842,702 |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 2,775,649 | $174.7 million | +213,495 |
| [Alnylam Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/alnylam-pharmaceuticals-inc-02043q107) | COM | 480,000 | $144.5 million | New |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 1,325,977 | $141.4 million | +71,489 |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 2,508,015 | $138.4 million | New |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 2,127,852 | $123.7 million | -2,665,168 |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 6,723,788 | $123.5 million | +3,574,895 |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 8,670,576 | $108.5 million | +650,000 |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 2,857,405 | $63.5 million | New |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 1,828,607 | $58.4 million | -226,384 |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 1,553,748 | $42.7 million | +888,497 |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 2,890,397 | $41.3 million | -252,040 |
| [Achieve Life Science Inc](https://specstream.ai/data/institutional-holders/achieve-life-science-inc-004468500) | COM | 4,951,856 | $32.3 million | New |
| [Vor Biopharma Inc](https://specstream.ai/data/institutional-holders/vor-biopharma-inc-929033207) | COM NEW | 1,750,000 | $32.2 million | No change |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 685,852 | $24.6 million | New |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 900,000 | $21.5 million | New |

## New positions in Q2 2026

7 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Alnylam Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/alnylam-pharmaceuticals-inc-02043q107) | COM | 480,000 | $144.5 million |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 2,508,015 | $138.4 million |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 2,857,405 | $63.5 million |
| [Achieve Life Science Inc](https://specstream.ai/data/institutional-holders/achieve-life-science-inc-004468500) | COM | 4,951,856 | $32.3 million |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 685,852 | $24.6 million |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 900,000 | $21.5 million |
| [Editas Medicine Inc](https://specstream.ai/data/institutional-holders/editas-medicine-inc-28106w103) | COM | 5,586,625 | $18.1 million |

## Positions exited in Q2 2026

14 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Arcellx Inc | COMMON STOCK | 5,774,016 | $663 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 3,574,048 | $142 million |
| Terns Pharmaceuticals Inc | COM | 2,216,499 | $116.9 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 1,480,857 | $97.6 million |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 772,473 | $86 million |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 2,744,399 | $81.9 million |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 1,226,080 | $60.3 million |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 625,000 | $57.7 million |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 525,000 | $33.2 million |
| [Urogen Pharma LTD](https://specstream.ai/data/institutional-holders/urogen-pharma-ltd-m96088105) | COM | 1,703,949 | $30.6 million |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 545,287 | $26.3 million |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 1,701,217 | $21.6 million |
| [Bridgebio Oncology Therapeut](https://specstream.ai/data/institutional-holders/bridgebio-oncology-therapeut-107924102) | COM NEW | 868,213 | $7.8 million |
| [Kalaris Therapeutics Inc](https://specstream.ai/data/institutional-holders/kalaris-therapeutics-inc-482929106) | COM | 700,000 | $4 million |

## Also on SpecStream

- [Paradigm Biocapital Advisors LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1855655/000185565526000014/0001855655-26-000014-index.htm)
- [Paradigm Biocapital Advisors LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/paradigm-biocapital-advisors-lp-312544)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Medical schools in New York, New York](https://specstream.ai/data/businesses/medical-schools/new-york-new-york-united-states)
- [Office cleaning companies in New York, New York](https://specstream.ai/data/businesses/office-cleaning-companies/new-york-new-york-united-states)
- [Plastic and reconstructive surgery practices in New York, New York](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/new-york-new-york-united-states)
- [Real estate investment firms in New York, New York](https://specstream.ai/data/businesses/real-estate-investment-firms/new-york-new-york-united-states)
- [Speech therapy clinics in New York, New York](https://specstream.ai/data/businesses/speech-therapy-clinics/new-york-new-york-united-states)
- [Textile manufacturers in New York, New York](https://specstream.ai/data/businesses/textile-manufacturers/new-york-new-york-united-states)
